Company intelligence
Guerbet
At Guerbet, we build lasting relationships so that we enable people to live better.
About Guerbet
Guerbet is a global leader in medical imaging, dedicated to improving patient care through innovation. With nearly a century of expertise, the company offers a comprehensive portfolio of pharmaceutical products, medical devices, and AI-driven solutions for diagnostic and interventional imaging. Guerbet invests 9% of its annual revenue in research and development, with dedicated innovation centers in France and the United States.
Verified activity
Signals from Guerbet
7 published signals
Presence & Recognition
Guerbet participated in the CIRSE 2026 event in Milan.
Reported by Guerbet
Presence & Recognition
Guerbet is hosting its next symposium at CIRSE 2026 at Booth D12 starting at 11:30 AM.
Reported by Guerbet
Presence & Recognition
Guerbet participated in the CIRSE 2026 scientific session to celebrate its centennial year and share insights on interventional radiology.
Reported by Francois Convenant
Presence & Recognition
Guerbet participated in Day 2 of the CIRSE 2026 conference at Booth D12.
Reported by Guerbet
Presence & Recognition
Guerbet is attending the CIRSE 2026 congress at Booth D12 from September 8th until September 10th, 2026, featuring Karim Boussebaa sharing his vision for the future of interventional radiology.
Reported by Guerbet
Operations & Supply
Guerbet launched its future evaporator and concentrateur project on the Guerbet site of Lanester, supported by France2030 and ADEME, to reduce emissions by 18% and value existing energy.
Reported by Guerbet
Products & Services
Guerbet launched Similac 360 Total Care Made With Whole Milk, the first liquid infant formula made with whole milk in the U.S.
Reported by Nicole Roberts